Speaker illustration

Mr Georg Wolff

University Hospital Duesseldorf, Duesseldorf (Germany)

Member of:

European Society of Cardiology
EAPCI
Heart Failure Association

Absolute treatment effects for the primary outcome and all-cause mortality in the cardiovascular outcome trials in type 2 diabetes: a meta-analysis of individual patient data

Event: ESC Congress 2022

Topic: Antidiabetic Pharmacotherapy

Session: Anti-diabetic pharmacotherapy in clinical practice

Thumbnail

Absolute treatment effects of novel oral antidiabetic drugs on cardiovascular mortality and hospitalization for heart failure: a meta-analysis of digitalized individual patient outcomes

Event: ESC Congress 2022

Topic: Antidiabetic Pharmacotherapy

Session: SGLT2 inhibitors in clinical practice

Thumbnail

Standardized risk management in catheterization procedures for non-ST-segment elevation myocardial infarction: associations with in-hospital clinical outcomes

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Non-ST-Elevation Myocardial Infarction (NSTEMI)

Session: Acute Coronary Syndromes ePosters

Thumbnail

Comparative evaluation of risk model performance for prediction of 30-day mortality in transcatheter aortic valve replacement

Event: ESC CONGRESS 2019

Topic: Aortic Valve Intervention

Session: Non-coronary cardiac intervention

Thumbnail

Efficacy and safety of perioperative aspirin therapy in non-cardiac surgery: a systematic review and comprehensive meta-analysis of randomized controlled trials

Event: ESC CONGRESS 2017

Topic: Drug therapy

Session: Remaining in the spotlight: antiplatelet agents

Thumbnail

Implantable cardioverter/defibrillators for primary prevention in dilated cardiomyopathy post-DANISH: an updated meta-analysis and systematic review of randomized controlled trials

Event: ESC CONGRESS 2017

Topic: Automatic implantable cardioverter / defibrillator

Session: ICD indications in 2017

Thumbnail

ESC 365 is supported by

logo Novo Nordisk